The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer

[1] Takeda K(2018)Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancer Esophagus 15 190-197

[2] Umezawa R(2018)Scoring system to predict the risk of surgical site infection in patients with esophageal cancer after esophagectomy with cervical anastomosis Surg Infect (Larchmt) 19 696-703

[3] Takahashi N(2010)Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people Age Ageing 39 412-423

[4] Yin LX(2016)Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma Dis Esophagus 29 627-633

[5] Chen BM(2017)Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer Ann Surg 266 822-830

[6] Zhao GF(2019)Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy Esophagus 16 345-351

[7] Cruz-Jentoft AJ(2017)Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis Ann Hepatol 16 107-114

[8] Baeyens JP(2017)Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: a retrospective cohort study Int J Surg 39 45-51

[9] Bauer JM(2014)Muscle wasting disease: a proposal for a new disease classification J Cachexia Sarcopenia Muscle 5 1-3

[10] Harada K(2012)A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) Ann Surg Oncol 19 68-74

[1] Takeda K(2018)Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancer Esophagus 15 190-197

[2] Umezawa R(2018)Scoring system to predict the risk of surgical site infection in patients with esophageal cancer after esophagectomy with cervical anastomosis Surg Infect (Larchmt) 19 696-703

[3] Takahashi N(2010)Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people Age Ageing 39 412-423

[4] Yin LX(2016)Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma Dis Esophagus 29 627-633

[5] Chen BM(2017)Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer Ann Surg 266 822-830

[6] Zhao GF(2019)Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy Esophagus 16 345-351

[7] Cruz-Jentoft AJ(2017)Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis Ann Hepatol 16 107-114

[8] Baeyens JP(2017)Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: a retrospective cohort study Int J Surg 39 45-51

[9] Bauer JM(2014)Muscle wasting disease: a proposal for a new disease classification J Cachexia Sarcopenia Muscle 5 1-3

[10] Harada K(2012)A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) Ann Surg Oncol 19 68-74